Biodegradable stent use for congenital heart disease

Research output: Contribution to journalReview articlepeer-review

Abstract

At the present time, there are no biodegradable stents available for use in pediatric patients with congenital heart disease, despite this population being most likely to benefit from a technology that will eventually disappear enabling all future treatment options and potentially future vessel growth. Current research is focused on identifying optimal biodegradable material and stent design to develop larger diameter stents with reasonable profile and strength to sustain the larger pulmonary arteries and aortic obstruction. In this article, we review the challenges faced with fabricating a larger diameter biodegradable stent and the currently available biodegradable scaffolds made for coronary and peripheral artery interventions and provide a summary of the current biodegradable stents being assessed for congenital heart disease applications.

Original languageEnglish (US)
Article number101349
JournalProgress in Pediatric Cardiology
Volume61
DOIs
StatePublished - Jun 2021

Keywords

  • Biodegradable stents
  • Bioresorbable polymers
  • Congenital heart disease
  • Pediatric stents
  • Poly-L-lactic-acid

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Pediatrics, Perinatology, and Child Health

Fingerprint

Dive into the research topics of 'Biodegradable stent use for congenital heart disease'. Together they form a unique fingerprint.

Cite this